thiotepa - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TEPADINA thiotepa 100 mg powder for injection vial AUST R: 370353Active ingredients:
thiotepa
Dosage form:
Injection, powder for
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800 195 055
|
From
03 May 2024
to
26 Jun 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative brand is available.
|
TEPADINA thiotepa 15 mg powder for injection vial AUST R: 370352Active ingredients:
thiotepa
Dosage form:
Injection, powder for
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800 195 055
|
From
30 Oct 2024
to
26 Jun 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative brand is available.
|
TEPADINA thiotepa 400 mg powder for injection and solvent dual chamber infusion bag AUST R: 370354Active ingredients:
thiotepa
Dosage form:
Injection, powder for
Sponsor:
Arrotex Pharmaceuticals Pty Ltd
Phone:
1800 195 055
|
From
08 Jan 2024
to
26 Jun 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative brand is available.
|